Tetsuhiko Nomura

Final 3‐year Results of the Dasatinib Discontinuation Trial in Patients With Chronic Myeloid Leukemia Who Received Dasatinib as a Second‐line Treatment

J. Sakamoto, M. Hino, S. Kimura, 2018, Clinical lymphoma, myeloma & leukemia.

Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells.

S. Fujita, O. Yoshie, H. Hasegawa, 2000, Blood.

Kobe University Repository : Kernel タイトル Tit le Significance of the Neutrophil Myeloperoxidase Index in Pat ients with Atherosclerot ic Diseases

A. Takarada, T. Sawada, Mitsuhiro Ito, 2018 .

Significance of the neutrophil myeloperoxidase index in patients with atherosclerotic diseases.

A. Takarada, H. Okamoto, T. Sawada, 2013, The Kobe journal of medical sciences.

Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft‐versus‐host disease after allogeneic hematopoietic stem cell transplantation

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2018, Transplant infectious disease : an official journal of the Transplantation Society.

Enhancement of anti‐tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI‐1‐ligand chemokine and stromal cell–derived factor‐1αchemokine genes

S. Fujita, H. Hasegawa, Masashi Kohno, 2001, International journal of cancer.

Chemokines and anti-cancer immunotherapy: anti-tumor effect of EBI1-ligand chemokine (ELC) and secondary lymphoid tissue chemokine (SLC).

H. Hasegawa, T. Nomura, Tetsuhiko Nomura, 2000, Anticancer research.

A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen

H. Matsuoka, Katsuya Yamamoto, H. Minami, 2016, International Journal of Hematology.

SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with alpha 5 beta 1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin.

S. Fujita, H. Hasegawa, K. Kishimoto, 1998, Journal of immunology.